This company applies bioinformatics, genomics, and data mining to identify and validate drug targets for various therapeutic modalities. They also discover biomarkers for pharmacodynamic, diagnostic, and patient selection purposes in drug development.
Funding
Funding not disclosed
Founders
Product
Problem
Drug discovery is a complex process that requires sophisticated bioinformatics analysis to identify potential drug targets and biomarkers. Many biotech and pharmaceutical companies, especially smaller ones, lack the in-house expertise and resources to effectively leverage bioinformatics for target identification, validation, and patient selection. This can lead to inefficiencies and increased risk of failure in drug development.
Solution
Monoceros Biosystems provides bioinformatics services to support drug discovery, offering expertise in target identification and validation, biomarker discovery, and patient selection strategies. The company leverages genomics, data mining, and artificial intelligence on a cloud-based platform to analyze complex biological data and identify promising drug targets across various therapeutic areas and modalities. By providing access to top-tier bioinformatics support, Monoceros Biosystems enables companies of all sizes to improve their drug discovery success rate and build lean, efficient R&D organizations. Their services cover experiment design, data interpretation, and clinical development support.
Target Audience
The primary customers are biotech and pharmaceutical companies of all sizes seeking bioinformatics support for drug discovery and development.
Features
- Target identification and validation using genomics and data mining techniques
- Biomarker discovery for pharmacodynamic studies, diagnostics, and patient selection
- Support for various therapeutic modalities, including small molecules, antibodies, and gene therapy
- Cloud-based, AI-enabled platform with key public datasets
- Experiment design and data interpretation expertise
- Dedicated team of analysts for real-time engagement and collaboration
- Support for all stages of drug discovery, from target identification to clinical development